178 related articles for article (PubMed ID: 14716513)
21. [Correlation of multiple gene changes with malignant phenotype of human gastric carcinoma].
Gao C; Lu Y
Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):671-5. PubMed ID: 9275549
[TBL] [Abstract][Full Text] [Related]
22. Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53.
Iannettoni MD; Lee SS; Bonnell MR; Sell TL; Whyte RI; Orringer MB; Beer DG
Ann Thorac Surg; 1996 Nov; 62(5):1460-5; discussion 1465-6. PubMed ID: 8893584
[TBL] [Abstract][Full Text] [Related]
23. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
[TBL] [Abstract][Full Text] [Related]
25. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
26. p53 genetic abnormalities and P-glycoprotein expression in stump and primary gastric carcinomas.
Oliver I; Lacueva J; Barberá V; Caldés T; Teruel A; Costa D; Medrano J; Pérez-Vázquez T; Quesada P; Ferragut J; Calpena R
Hepatogastroenterology; 2007 Mar; 54(74):377-81. PubMed ID: 17523278
[TBL] [Abstract][Full Text] [Related]
27. High incidence of nuclear accumulation of p53 protein in gastric cancer.
Uchino S; Noguchi M; Hirota T; Itabashi M; Saito T; Kobayashi M; Hirohashi S
Jpn J Clin Oncol; 1992 Aug; 22(4):225-31. PubMed ID: 1279244
[TBL] [Abstract][Full Text] [Related]
28. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
29. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
30. p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach.
Lee WA; Woo DK; Kim YI; Kim WH
Pathol Res Pract; 1999; 195(11):747-52. PubMed ID: 10605694
[TBL] [Abstract][Full Text] [Related]
31. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma.
Naritomi K; Futami K; Arima S; Iwashita A
Anticancer Res; 2003; 23(6a):4411-22. PubMed ID: 14666728
[TBL] [Abstract][Full Text] [Related]
32. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.
Marsman WA; Birjmohun RS; van Rees BP; Caspers E; Johan G; Offerhaus A; Bosma PJ; Jan J; van Lanschot B
Clin Cancer Res; 2004 Dec; 10(24):8479-85. PubMed ID: 15623628
[TBL] [Abstract][Full Text] [Related]
34. Genomic and Pathologic Profiling of Very Well-Differentiated Gastric Adenocarcinoma of Intestinal Type: A Study With Emphasis on Diffuse-Type Transformation.
Rokutan H; Arai Y; Kunita A; Yamasaki S; Nakamura H; Hama N; Nakayama A; Hosoda F; Totoki Y; Fujishiro M; Seto Y; Shibata T; Ushiku T
Am J Surg Pathol; 2024 Jun; 48(6):652-661. PubMed ID: 38584451
[TBL] [Abstract][Full Text] [Related]
35. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach.
Tamura G; Sakata K; Maesawa C; Suzuki Y; Terashima M; Satoh K; Sekiyama S; Suzuki A; Eda Y; Satodate R
Cancer Res; 1995 May; 55(9):1933-6. PubMed ID: 7728762
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
[TBL] [Abstract][Full Text] [Related]
37. Analysis of p53 abnormalities in endoscopic gastric biopsies.
Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
39. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53.
Yoshimura A; Sugihara H; Ling ZQ; Peng DF; Mukaisho K; Fujiyama Y; Hattori T
Pathobiology; 2006; 73(1):40-9. PubMed ID: 16785766
[TBL] [Abstract][Full Text] [Related]
40. Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]